Catherine Hyams

@Eurosurveillanc @AChatzilena @adamhfinn @leondanon @BristolUncover @BristolUni @uhbwNHS @NorthBristolNHS Our findings support the booster immunisation programmes implemented in several European countries, that advised the use of #BA1/ancestral #mRNA #bivalent booster doses in individuals at high risk of severe #COVID19 eurosurveillance.org/content/10.280… @AChatzilena @leondanon @adamhfinn

@tb_doc @HugoResp @NHSBartsHealth For a review/summary article: openres.ersjournals.com/content/6/1/00…

@HugoResp @NHSBartsHealth @cathyams has also published similar. pubmed.ncbi.nlm.nih.gov/31956656/

@tb_doc hi Will, hope you’re well? Quick q. Seem to recall an audit of the utility of urinary antigen tests at Barts & the London that showed ?~1000 tests, no legionella +ve, handful of pneumococcal +ve but all already on appropriate Abx. Can’t find now… can you help…?

So pleased this one is out: medrxiv.org/content/10.110… Multiplex panel tests have an inherent uncertainty that is typically ignored when calculating prevalence, and develop methods to fix it. w @rjchallen @adamhfinn @cathyams @AChatzilena @KrasiTsaneva

@Eurosurveillanc @AChatzilena @adamhfinn @leondanon @BristolUncover @BristolUni @uhbwNHS @NorthBristolNHS This work from AvonCAP couldn't be done without the amazing @ResearchNBT @uhbwNHS #NHS & research team, working collaboratively with @BristolUni, @UKHSA & academics

@Eurosurveillanc @AChatzilena @adamhfinn @leondanon @BristolUncover @BristolUni @uhbwNHS @NorthBristolNHS Our findings support the booster immunisation programmes implemented in several European countries, that advised the use of #BA1/ancestral #mRNA #bivalent booster doses in individuals at high risk of severe #COVID19 eurosurveillance.org/content/10.280… @AChatzilena @leondanon @adamhfinn

Understanding protection from #COVID19 boosters against #SARSCoV2 infection is a priority. We compared protection against hospitalisation in 2022 UK booster campaigns: original monovalent mRNA vaccine vs bivalent mRNA booster @leondanon @AChatzilena @adamhfinn @BristolUncover

@alice_ahalliday @AshToye_Bristol @BristolARU @BristolUni @leondanon @rjchallen @BristolUncover This analysis provides evidence blood group status may influence outcome of respiratory infection: group A have increased risk of hospitalisation & RhD-positive patients having reduced cardiovascular complications. @adamhfinn @BristolUni @BristolIandI onlinelibrary.wiley.com/doi/full/10.11…

@alice_ahalliday @AshToye_Bristol @BristolARU @BristolUni We found blood group A and Rh neg patients were over represented in respiratory infection. ABO group didn't influence cardiovascular complication risk; but, RhD-positive pneumonia patient had reduced risk of cardiovascular complications @leondanon @rjchallen @BristolUncover

What effect does ABO & Rhesus status have on outcomes with respiratory infection? Read the paper from @alice_ahalliday and @AshToye_Bristol and AvonCAP, @BristolARU and @BristolUni to find out! onlinelibrary.wiley.com/doi/full/10.11…

Excited to share my first paper from my @TheBHF PhD on ABO & Rh blood groups on respiratory infection hospitalisation & outcome! Huge thanks to my supervisors @cathyams & @AshToye_Bristol & the AvonCAP research team for making this possible 👩‍🔬onlinelibrary.wiley.com/doi/10.1111/bj…

Great to see this blood groups and non-SARS-CoV2 respiratory infection paper out by our @TheBHF funded PhD student @AliceHathaaa in a continuation of our Avon CAP Research team collaboration with @adamhfinn @cathyams onlinelibrary.wiley.com/doi/10.1111/bj…

#CMEActivity, Serotype distribution and disease severity in adults hospitalized with #Streptococcus #pneumoniae infection, Bristol and Bath, UK, 2006‒2022, EID journal, bit.ly/45kvyoU (Authors: @cathyams, Robert Challen)

Super excited!! Our paper on #pneumococcal #serotypes was accepted in @EIDjournal More like unbelievably excited... Keeping calm... Obviously not @adamhfinn @BristolARU @leondanon @rjchallen @BristolUni @ResearchNBT @BristolUncover @UKHSA @ShamezLadhani doi.org/10.1101/2023.0…

Rishi Sunak said today at #PMQs that rising NHS waiting lists is down to industrial action. Well how about the last 13 years of rising waiting lists?

As always, this important work cannot be undertaken without the fantastic #NHS and @UKHSA, and the people who collaborate to deliver #research that we hope makes #meaningful change @BristolARU @NorthBristolNHS @uhbwNHS @BristolUni @BristolUncover @adamhfinn @theotherdodd @pfizer

We also found a 9.8% 30-day mortality rate among non #SARSCoV2 #COPD patients, highlighting the burden of #COPD during the #COVID19 #pandemic. #COPD COPD exacerbation-related morbidity and mortality remain substantial, and there's much work to do. @theotherdodd @BristolARU

Are #COPD #exacerbations due to #SARSCoV2 more severe than those due to other infections or non-infectious causes? Our latest paper in @EditorJRSM tries to address this question. @theotherdodd @adamhfinn @leondanon @rjchallen @BristolARU @BristolUni journals.sagepub.com/doi/full/10.11…